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Abstract. 
 
Laminin 5 (
 
a
 
3
 
b
 
3
 
g
 
2
 
) distribution in the human 
thymus was investigated by immunofluorescence on 
frozen sections with anti-
 
a
 
3
 
, -
 
b
 
3
 
, and -
 
g
 
2
 
 mAbs. In addi-
tion to a linear staining of subcapsular basal laminae, 
the three mAbs give a disperse staining in the paren-
chyma restricted to the medullary area on a subset of 
stellate epithelial cells and vessel structures. We also 
found that laminin 5 may influence mature human thy-
mocyte expansion; while bulk laminin and laminin 2, 
when cross-linked, are comitogenic with a TCR signal, 
cross-linked laminin 5 has no effect. By contrast, solu-
ble laminin 5 inhibits thymocyte proliferation induced 
by a TCR signal. This is accompanied by a particular 
pattern of inhibition of early tyrosine kinases, including 
Zap 70 and p59
 
fyn
 
 inhibition, but not overall inhibition 
of p56
 
lck
 
. Using a mAb specific for 
 
a
 
6
 
b
 
4
 
 integrins, we 
observed that while 
 
a
 
3
 
b
 
1
 
 are known to be uniformly 
present on all thymocytes, 
 
a
 
6
 
b
 
4
 
 expression parallels 
thymocyte maturation; thus a correspondence exists be-
tween laminin 5 in the thymic medulla and 
 
a
 
6
 
b
 
4
 
 on ma-
ture thymocytes. Moreover, the soluble Ab against 
 
a
 
6
 
b
 
4
 
 
inhibits thymocyte proliferation and reproduces the 
same pattern of tyrosine kinase phosphorylation sug-
gesting that 
 
a
 
6
 
b
 
4
 
 is involved in laminin 5Ðinduced mod-
ulation of T cell activation.
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L
 
AMININS
 
 are the major constituents of basal laminae;
together with other extracellular matrix compo-
nents (ECM)
 
1
 
 they contribute, by binding cell sur-
face receptors such as integrins, to maintain epithelial tis-
sue integrity (3, 38, 76). In addition to their mechanical
role, they are important signaling molecules with the abil-
ity to strongly influence cellular programs, promoting dif-
ferentiation and migration, proliferation and activation
(13, 39, 40). Thus, they are influential molecules in the de-
velopment (1, 59, 62) and repair (29, 30, 53) of many tis-
sues.
Laminins are heterotrimers where the 
 
a
 
 chain is critical
for cell/matrix interactions (37). Among laminin isoforms
(4, 67), laminin 5 (epiligrin, kalinin, nicein) is somewhat
unique and is preferentially found in basement mem-
branes underlying squamous and transitional epithelia (4).
From a structural viewpoint, the molecule displays a par-
ticular chain composition (
 
a
 
3
 
b
 
3
 
g
 
2
 
) and has been character-
ized as a 105-nm rod-like molecule from the conditioned
medium of normal human keratinocytes (49). Studies per-
formed with extracts of human amnion revealed that, in
addition to monomeric molecules, much of the laminin 5
isolated is covalently associated with laminin 6 (
 
a
 
3
 
b
 
1
 
g
 
1
 
)
and 7 (
 
a
 
3
 
b
 
2
 
g
 
1
 
) (8). Whether these complexes are located in
other basement membranes remains to be shown. Laminin
5 has the ability to bind the NH
 
2
 
-terminal domain of type
VII collagen and is believed to strongly connect cells to
anchoring fibrils in skin (51). Laminin 5 has been identi-
fied as a ligand for the integrins 
 
a
 
3
 
b
 
1
 
 (7, 48) and 
 
a
 
6
 
b
 
4
 
 (44,
60). From a functional viewpoint, laminin 5 plays a major
mechanical role in maintaining the basal layer of epithelia
(1, 3, 6, 7, 14, 15, 23, 49, 51, 52), and it is also increased in
the early stages of wound repair (30, 53). Furthermore, ac-
cumulated evidence suggests that laminin 5 is a signaling
molecule that is particularly involved in controlling cell
migration and tumor cell expansion (16, 26, 27, 39, 46).
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1. 
 
Abbreviations used in this paper:
 
 APY, anti-phosphotyrosine; Ab, anti-
body; ECM, extracellular matrix; GAR, goat antiÐrabbit immuno-
globulins; IP, immunoprecipitation; pAb, polyclonal antibody; PE, phyco-
erythrin. 
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The thymus can be regarded as a mesh of epithelial cells
surrounding maturing T cells; thus, ECM components and
integrins displayed by thymocytes appear to strongly influ-
ence T cell differentiation/maturation (5, 10, 12, 20, 31, 43,
54Ð56, 69, 73, 74). Mice deficient in merosin, for example,
suffer from abnormal T cell development (31). Since the
presence of laminin 5 has been found within the human
thymus (25, 42, 72), this work was undertaken to docu-
ment expression and functional influence of laminin 5 and
its cellular receptors during thymocyte maturation. We
show here that laminin 5 displays a peculiar tissue distribu-
tion in the human thymus. In addition, we show that lami-
nin 5, in soluble form, provides mature thymocytes with an
inhibitory signal upon stimulation via the CD3ÐTCR com-
plex which can be reproduced by an anti-
 
a
 
6 mAb specific
for 
 
a
 
6
 
b
 
4
 
. We have already shown that ligands to 
 
b
 
1 inte-
grins
 
,
 
 when used in soluble form, inhibit T cell activation
triggered via the CD3ÐTCR complex (19, 34, 65). We now
report that
 
 
 
a
 
6
 
b
 
4
 
 integrins can also trigger a similar effect
after ligation with soluble laminin 5.
 
Materials and Methods
 
Materials
 
Human laminin 5 was obtained by immunopurification of the conditioned
medium of SCC25 cells (squamous cell carcinoma) using the 6F12 mAb
coupled to CNBr-activated Sepharose 4B (Pharmacia Fine Chemicals).
Before this step, medium was passed sequentially over 25 ml of gelatinÐ
Sepharose (Pharmacia Fine Chemicals) in order to remove fibronectin.
Molecular mass of the eluted laminin 5 was analyzed by SDS-PAGE and
revealed the presence of the trimer 
 
a
 
3
 
b
 
3
 
g
 
2
 
 only. Purity of the molecule
preparation was checked by immunoblotting using a panel of several
monoclonal and polyclonal antibodies as previously described (48, 50).
Laminin 2 was obtained from Chemicon. Human fibronectin, protein
AÐSepharose CL 4B, PMSF, leupeptin, aprotinin, NP-40, and BSA were
all purchased from Sigma Chemical Co.; human IL-2 was from R&D Sys-
tems Inc. Chemicals for PAGE were from Bio-Rad Laboratories. Anti-
fading mounting medium Citifluor was obtained from Citifluor Chemical
Laboratory. [
 
3
 
H]thymidine and 
 
125
 
I were obtained from Commisariat 
lÕEnergie Atomique. ECL reagents were purchased from Amersham.
 
Antibodies
 
The BM165 mAb (mouse IgG1), specific for 
 
a
 
3 chain of human laminin 5
was produced as previously described (49). The 6F12 mAb, specific for 
 
b
 
3
chain of human laminin 5, was produced as previously described (33). The
GB3 mAb (70) specific for 
 
g
 
2 chain of human laminin 5, was from Accu-
rate and Specific Corporation. The human CD49f (
 
a
 
6 integrin chain)
mAb S3-41 (mouse, IgG1) was produced as previously described (24). The
human CD49f mAb GOH3 (rat IgG1; 61) was obtained from Immuno-
tech. The human CD49f mAbs 135 13C (rat IgG2a), J8H (mouse IgG1),
BQ16 (mouse IgG1), and 450 30A1 (mouse IgG1) were obtained from the
5th International Workshop of Leukocyte Typing. The CD49c mAb (
 
a
 
3
integrin chain) P1B5 was obtained from Becton Dickinson. Human
CD104 (
 
b
 
4 integrin chain) mAb 3E1F6 was a gift from Dr. Kennel (Oak
Ridge National Laboratory, Oak Ridge, Tennessee). Anti-p67 high affin-
ity non-integrin laminin receptor mAb MPLR2 was provided by Dr. Col-
naghi (Istituto Nazionale Tumori, Milan, Italy) as ascites fluid. CD28
mAb 9.3 (mouse IgG2a) was kindly provided by Dr. Ledbetter (Pharma-
ceutic Research Institute, Bristol Myers Squibb, Seattle, WA). Human
CD29 (
 
b
 
1 integrin chain) mAb K20 (mouse IgG2a), CD3 mAb X3 (mouse
IgG2a), and CD2 mAbs GT2 (mouse IgG1) and D66 (mouse IgM) were
generated in our laboratory. The antiÐZap 70 rabbit antibody was directed
against amino acids 485 to 499 of the human ZAP 70 sequence as previ-
ously described (68). Rabbit anti-human p56
 
lck
 
 and anti-p59
 
fyn
 
 Abs and
peroxidase (HRP) conjugated anti-phosphotyrosine (4G10) were obtained
from Upstate Biotechnology Inc. The goat antiÐmouse, antiÐrat, or antiÐ
rabbit antibodies, alone or coupled with fluorochromes or peroxidase, as
well as irrelevant mouse IgG1, were purchased from Dakopatts.
 
Cell Culture and Tissue
 
Normal thymi were obtained from children (
 
,
 
4 yr) undergoing cardiac
surgery. Thymocytes were prepared by physical disruption of the tissue
and washes in RPMI/10% FCS. Jurkat (T lymphoma), HT29 (human co-
lon carcinoma), and K562 (myelogenous leukemia) cell lines were ob-
tained from the American Type Culture Collection.
Thymocytes, human cell lines Jurkat and K562 were cultured in RPMI
1640 (GIBCO BRL) supplemented with 10% FCS. Human colon carci-
noma cell line HT29 was cultured in DME (GIBCO BRL) 5% FCS. All
media were supplemented with 50 U/ml penicillin, 50 
 
m
 
g/ml streptomycin,
2 mM 
 
L
 
-glutamine, and 1 mM pyruvate (Merck).
 
Immunohistochemistry
 
For immunohistochemistry, specimens of human thymi were fragmented,
immediately frozen in liquid nitrogen, and stored at 
 
2
 
70
 
8
 
C.
Frozen sections (4 
 
m
 
m thick) were processed for indirect immunofluo-
rescence, using a single label fluorescein technique. Air-dried cryostat sec-
tions were incubated for 30 min with the primary antibody diluted in PBS,
at room temperature. Antibody binding was then detected by incubating
the sections with FITC-conjugated rat antiÐmouse secondary antibody
(F(ab)
 
9
 
2
 
) fragments (Dakopatts), diluted 1:50 in PBS, for 30 min at room
temperature. Cell nuclei were labeled with 0.5% propidium iodide (Sigma
Chemical Co.). After final washing in PBS, the sections were mounted in
Citifluor (Plano) and examined with a laser scanning confocal microscope
(Ultima Meridian; DGL Bioscience). Indirect double staining of thymic
epithelial cells was performed with the anti-laminin 5 mAb BM165
(mouse IgG1) and the anti-keratin mAb CK19 (mouse IgM) using iso-
type-specific secondary antibodies, i.e., FITC-conjugated goat antiÐmouse
IgM, obtained from Chemicon, and rabbit antiÐmouse IgG1 (Dakopatts)
revealed with phycoerythrin (PE)-conjugated goat antiÐrabbit Ig (Dako-
patts). After final washing in PBS, sections were mounted in Citifluor (Plano)
and examined with a laser scanning confocal microscope (Ultima Merid-
ian; DGL Bioscience).
 
Proliferation Assays
 
Cell proliferation assays were performed in triplicate in 96-well culture
plates (Nunc). Thymocytes at 10
 
5
 
 cells/well were cultured in 0.2 ml of
RPMI 1640 with 10% FCS. Coating of the CD3 mAb was carried out by
overnight incubation at 4
 
8
 
C with CD3 mAb (
 
3
 
3, 10 
 
m
 
g/ml) diluted in PBS.
Each well was then washed three times with PBS. To saturate the plastic
before using soluble reagents, RPMI with 10% FCS was added for 2 h,
then the wells were washed three more times with PBS. Cells were added
in culture medium containing soluble laminins or Abs before the addition
of rIL-2 (5 ng/ml).
For costimulation assays, CD3 mAb was coimmobilized with another
mAb or with an ECM. A first overnight incubation at 4
 
8
 
C was carried out
with an ECM component (laminin 5, laminin 2, or fibronectin) or mAbs
diluted in PBS followed, after washing, by immobilization of CD3 mAb.
Cells were incubated at 37
 
8
 
C in a 5% CO
 
2
 
 humidified atmosphere for
4 d, and 1 
 
m
 
Ci of [
 
3
 
H]thymidine (2 Ci/mmol; CEA) was added for the final
18 h. Cells were harvested onto filter paper using a semiautomatic cell
harvester (Skatron) and thymidine incorporation was measured in a liquid
scintillation counter (Beckman Instruments Inc.).
 
Apoptosis Assays
 
Apoptosis was determined by incubating cells previously cultivated as de-
scribed above with Hoechst 33342 (Interchim), 30 min at 37
 
8
 
C. Results
were analyzed on a FACStar
 
¨
 
 cytometer (Becton Dickinson).
 
Immunofluorescence Analysis of Isolated Cells
 
Cells were washed three times with PBS and incubated at 4
 
8
 
C for 30 min
in the dark in 100 
 
m
 
l PBS, 0.1% NaN
 
3
 
, and 0.1% BSA with saturating con-
centration of mAbs, washed three times and resuspended at a density of
3 
 
3
 
 10
 
6
 
 cells/ml. Indirect labeling was performed by adding goat antiÐ
mouse PE-conjugated F(ab)
 
9
 
2
 
 fragments (Dako). This reagent also binds
to rat IgG. Double staining was performed using indirect labeling with a
primary mAb revealed with antiÐmouse (PE) conjugated F(ab)
 
9
 
2
 
 frag-
ments (Dako) followed, after washes, by staining with (FITC) conjugated
CD3. Controls included cells incubated with mouse IgG of the relevant
subclasses. Analysis was performed on a FACScan
 
¨
 
 (Becton Dickinson). 
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Radioiodination of Cells, Immunoprecipitation, and 
Immunoblot Analysis
 
Surface labeling of cells with 
 
125
 
I (1 mCi; Amersham) was performed by
the lactoperoxidase method, as previously described (11). For immuno-
precipitation, cells were washed three times, and lysed in ice-cold lysis
buffer (stop buffer with 1% NP-40, 10 
 
m
 
g/ml leupeptin, 1 mM PMSF, and
1,000 U/ml aprotinin) for 30 min on ice. Immunoprecipitation with indi-
cated mAbs (10 
 
m
 
g) adsorbed on protein AÐSepharose 3 h at 4
 
8
 
C under
agitation was then performed on precleared lysates. Sepharose-bound im-
mune complexes were washed three times in TNN buffer (50 mM Tris [pH
7.8], 250 mM NaCl, 0.1% NP-40), then eluted into reduced Laemmli
buffer. Immunoprecipitated proteins were analyzed by SDS-PAGE on a
7.5% gel and revelation was performed by autoradiography. Unlabeled
immunoprecipitated proteins were analyzed by SDS-PAGE on a 7.5% gel
and then electroblotted onto Immobilon
 
 P 
 
membrane (Millipore). The
blotted membrane was saturated overnight at 4
 
8
 
C in a buffer containing
5% BSA, 100 mM Tris, 1.4 M NaCl, pH 7.4, then incubated overnight with
the anti-
 
a
 
6 mAb S3-41. Immunolabeling was revealed by chemilumines-
cence (ECL) after reaction with goat antiÐmouse immunoglobulins in
conjunction with HRP.
 
Anti-Phosphotyrosine Immunoblot Analysis
 
Cells at 20 
 
3
 
 10
 
6
 
/ml in RPMI 5% FCS were incubated with Abs at 37
 
8
 
C
for various time intervals. Activation was stopped by addition of 1 ml of
ice-cold stop buffer (20 mM Hepes [pH 7.4], 150 mM NaCl, 100 mM NaF,
10 mM EDTA, 10 mM Na
 
4
 
P
 
2
 
O
 
7
 
, and 2 mM Na
 
3
 
VO
 
4
 
). Cells were spun
down and the pellets were resuspended in lysis buffer (stop buffer with
1% NP-40, 10 
 
m
 
g/ml leupeptin, 1 mM PMSF, and 1,000 U/ml aprotinin)
and incubated on ice for 30 min. After centrifugation (15,000 
 
g
 
 for 15 min)
supernatants were incubated with Abs for 4 h at 4
 
8C with shaking, fol-
lowed by 1 h with RAM adsorbed on protein AÐSepharose. Pellets were
washed four times with lysis buffer containing 1% NP-40, then once in
stop buffer without detergent before mixing with Laemmli buffer contain-
ing 3% (final volume) SDS. For reduction, the loading buffer contained
0.75 M 2 ME. Proteins were analyzed by SDS-PAGE, then electroblotted
onto Immobilon P membrane (Millipore). The blots were saturated over-
night at 48C in a buffer containing 5% BSA, 100 mM Tris, 1.4 M NaCl, pH
7.4, then incubated overnight with the appropriate antibodies (HRP con-
jugated anti-phosphotyrosine mAb [4G10], pAb anti-lck, pAb anti-fyn, or
pAb antiÐZap 70). For anti-lck, anti-fyn, and antiÐZap 70 immunoblots,
membranes were washed and incubated 1 h with a HRP-conjugated goat
antiÐrabbit antibody. After washing, the immunolabeling was revealed by
ECL (enhanced chemiluminescence) analysis system. HRP-conjugated
anti-phosphotyrosine Ab was also used followed by ECL. For reprobing,
the membranes were submerged in stripping buffer (100 mM 2 NE, 2%
SDS, 62.5 mM Tris-HCl, pH 6.7) and incubated at 508C for 30 min. After
washing, the membrane was blocked and immunodetection was per-
formed as described.
Results
Immunohistolocalization of Laminin 5 on Post-natal 
Human Thymus Sections
We investigated laminin 5 (a3b3g2) expression in the hu-
man thymus by immunofluorescence, using mAbs specific
for the a3 chain (BM165 [49]; Fig. 1, a and b), for the b3
Figure 1. Immunofluores-
cence on frozen human thymus
section was performed with
anti-laminin 5 chain mAbs:
the anti-a3 chain BM165 (a
and b), the anti-b3 chain
6F12 (c); the anti-g2 chain
GB3 (d). mAb staining was
revealed by FITC conjugated
goat antiÐmouse F(ab)92
fragments and analysis was
performed by laser scanning
confocal microscopy. Varia-
tions of cellular density be-
tween cortex (C) and me-
dulla (M), were revealed by
cell nuclear staining with
propidium iodide. Single ar-
rows designate the subcapsu-
lar basal laminae. Double
arrows show examples of
laminin 5 positive epithelial
cells. b is a view constructed
by the juxtaposition of suc-
cessive areas scanned at a
larger magnification.The Journal of Cell Biology, Volume 144, 1999 566
chain (6F12 [33]; Fig. 1 c), or for the g2 chain (GB3, [35];
Fig. 1 d). Staining of laminin 5 was performed together
with a nuclear counter-staining with propidium iodide
(Fig. 1, aÐd; Fig. 2, a and b) in order to recognize the corti-
cal (C) and the medullary (M) regions. All three mAbs
stained strongly the medullary area of parenchyma and
the basal laminae from subcapsular cortex, consistent with
the presence of laminin 5 in these areas. More precisely,
laminin 5 was localized in stellate keratin positive epithe-
lial cells (Fig. 2, c and d) and in the basal laminae of vessels,
including small vessels and capillary structures, together
with endothelial cells of the larger vessels (Fig. 1 b, arrows;
Fig. 2, a and b). Of note, a more intense staining at the cor-
ticomedullary junction was only visible with the anti-a3
mAb BM165, suggesting that laminin 6 (a3b1g1) and/or 7
(a3b2g1) could be associated with laminin 5 in this area. As
to the cortex, mAbs stained very scattered structures that
corresponded for the most part to vascular structures.
Laminin 5 and Laminin 2 Have Distinct Effects on 
Thymocyte Proliferation: The Soluble Form of Laminin 
5 Inhibits Proliferation of Human Thymocytes 
Stimulated via the CD3ÐTCR Complex
Since laminins were shown to influence the functional pro-
gram of numerous cell types, and in particular bulk prepa-
rations of laminins were shown to deliver coactivation sig-
nals to T cells (10, 58, 66), we investigated the effects of
purified laminin 5 on thymocytes. When we coimmobi-
lized laminin 5 on plastic, this induced a weak costimula-
tion with a CD3ÐTCR signal, as compared with coated fi-
bronectin or laminin 2 (a2b1g1), another laminin isoform
found in the thymus (10; Fig. 3). We then investigated the
effect of laminin 5 and laminin 2 presented in soluble
form; soluble laminin 5 clearly inhibited the proliferation
of thymocytes stimulated via the CD3ÐTCR (Fig. 4 a). The
inhibition was dose-dependent reaching a maximum of
50%, in terms of [3H]thymidine incorporation, at 5 mg/ml.
Over six independent experiments we saw a quite signifi-
cant inhibition down to 1 mg/ml (z30%). We checked the
specificity of laminin 5Ðinduced inhibition by adding the
anti-a3 chain mAb BM165, which recognizes an epitope
involved in the interaction of laminin 5 with cells. BM165
abolished the inhibiting effect observed with soluble lami-
nin 5 alone (Fig. 4 a). Conversely, no inhibition was seen
when we added, instead of laminin 5, increasing amounts
of soluble human laminin 2 (Fig. 4 a).
Inhibition was seen only when T cells were stimulated
via the CD3ÐTCR; we observed no inhibition when thy-
mocytes were induced to proliferate via a mitogenic pair
Figure 2. Frozen human thy-
mus section stained with anti-
laminin 5 a3 chain mAb
BM165. (a and b) BM165
staining on vessels; staining
was revealed by FITC conju-
gated goat antiÐmouse
F(ab)92 fragments and analy-
sis was performed by laser
scanning confocal micros-
copy. Cell nuclei were
stained with propidium io-
dide. (c and d) BM165 stain-
ing on stellate thymic epithe-
lial cells; double staining
obtained with mAb BM165
revealed by rabbit antiÐ
mouse IgG1 F(ab)92 frag-
ments followed by PE conju-
gated goat antiÐrabbit
F(ab)92 fragments, and the
anti-keratin CK19 revealed
by FITC conjugated goat
antiÐmouse IgM Ab. Con-
trols made with secondary
Abs gave no staining (not
shown).Vivinus-Nebot et al. Laminin 5 Control Human Thymocyte Proliferation via a6b4 567
of CD2 mAbs (Fig. 4 b). We verified that inhibition of pro-
liferation was not related to apoptosis by incubating cells
with Hoechst 342 30 min at 378C. Results analyzed on a
FACStar¨ cytometer (Becton Dickinson) did not reveal
any sign of apoptosis (not shown).
Inhibition by Soluble Laminin 5 of Early Kinase 
Phosphorylations Activated via the CD3ÐTCR Complex
We tested soluble laminin 5 effects on early kinase phos-
phorylation events. Since Jurkat cells express a low density
of  a6b4 we selected by cytofluorometry cells expressing
a6b4 in similar density as CD3high thymocytes (not shown).
These cells were activated with a CD3 mAb (33, 10 mg/ml)
during 2.5 min at 378C, with or without soluble laminin 5.
Immunoprecipitation of Zap 70, p56lck, or p59fyn was car-
ried out on activated cell lysates, after which precipitated
proteins were transferred on Immobilon. Membranes were
then incubated with HRP conjugated anti-phosphoty-
rosine antibody. Results were revealed by ECL system.
We observed that the addition of 1 mg/ml of soluble lami-
nin 5 was sufficient to induce an inhibition of Zap 70 (Fig.
5 a) and p59fyn tyrosine phosphorylation (Fig. 5 c). By con-
trast, the addition of soluble laminin 5, up to 5 mg/ml, a
concentration fully efficient in proliferation assays, did not
induce a significant inhibition of p56lck phosphorylation
(Fig. 5 b). Membranes were stripped, blocked, and re-
probed with the precipitating antibody, i.e., respectively
antiÐZap 70 (Fig. 5 a), anti-lck (Fig. 5 b), and anti-fyn (Fig.
5 c), respectively, in order to verify amounts of precipi-
tated material in each lane.
Identification of an Anti-a6 mAb Specific for a6b4: 
Evidence for Distinct Forms of a6 Chains Paired with 
b1 and b4 Chains
Next, we investigated whether the effect of laminin 5
would be mediated by a6b4, a3b1, or both. We tested a bat-
tery of anti-a6 mAbs for their reactivity in flow cytometry
with dispersed human thymocytes (135 13C [rat IgG2a];
J8H, BQ16, 450 30A1, S3-41 [mouse IgG1]; reference 24)
Figure 3. Comparison of costimulating effects of fibronectin,
laminin 2 and laminin 5 when presented in cross-linked form to
thymocytes. Indicated amounts of purified ECM components
were first added to culture wells. After overnight incubation at
48C, ECM solutions were discarded and wells were washed. CD3
mAb was next incubated in the culture wells for an additional 12 h
at 48C. After further washes, cells were added (105/well) to the
culture wells and incubated for 4 d with addition of [3H]thymi-
dine for the final 18 h.
Figure 4. Laminin 5 but not laminin 2, when added in soluble
form, inhibits human thymocyte proliferation induced by CD3 1
IL-2. (a) CD3 antibodies were first incubated overnight in culture
wells. Next, 10% FCS in RPMI was added and incubated in order
to minimize further protein adsorption on plastic. After washing,
cells (105/well) were added in culture medium containing IL-2 (5
ng/ml) and laminin 5 or laminin 2. Cultures were also performed
in the presence of 10 mg/ml anti-laminin 5 mAb BM165. (b) Ef-
fect of soluble laminin 5 on thymocyte proliferation induced by a
mitogenic CD2 mAb pair (GT2 1 D66, 10 mg/ml) plus IL-2.The Journal of Cell Biology, Volume 144, 1999 568
and the widely used anti-a6 GOH3 [rat IgG1]; reference
61). We noticed that the mouse mAb S3-41 displayed a pe-
culiar reactivity as compared with other anti-a6 mAbs,
strikingly similar to the reactivity of the anti-b4 mAb
3E1F6 (Fig. 6). S3-41, as 3E1F6, did not react with the
most immature CD3low thymocytes. Moreover, staining by
S3-41 and 3E1F6 increased with the density of CD3, which
indicates the level of maturation of thymocytes (Fig. 6).
This pattern of reactivity was in marked contrast to the
pattern given by the other anti-a6 mAbs tested including
GOH3, which stained immature CD3low thymocytes. Of
note, peripheral blood T lymphocytes were equally stained
with GOH3 and S3-41 (not shown).
To confirm that S3-41 would react only with the a6
chains linked to b4, we performed sequential immunopre-
cipitations using the colon carcinoma cell line HT29, which
expresses high densities of both a6b1 and a6b4. Cells were
lysed with 1% NP-40 and lysates were depleted of b1 or b4
integrins by two successive immunoprecipitations either
with the anti-b1 mAb K20 or the anti-b4 mAb 3E1F6. De-
pleted lysates were then immunoprecipitated with either
the anti-a6 mAbs S3-41 or GOH3 (Fig. 7 a). It can be seen
that GOH3 was still able to immunoprecipitate residual
material when lysates were depleted of either b1 or b4 in-
tegrins (Fig. 7 a, middle, lane 3; right, lane 3). In contrast,
S3-41 did not precipitate any residual material when ly-
sates were depleted of b4 integrins (Fig. 7 a, right, lane 2)
whereas it remained fully reactive when lysates were de-
pleted of b1 integrins (Fig. 7 a, middle, lane 2). Thus, if
GOH3 immunoprecipitates a6 chains associated with ei-
ther b1 or b4 chains, S3-41 recognizes only a6 chains
paired with b4. These results were confirmed by immuno-
blotting experiments with S3-41. Cell lysates were first im-
munoprecipitated either with the anti-b1 mAb K20 or the
anti-b4 3E1F6. Fig. 7 b shows that S3-41 recognized only
the a6 chains that coimmunoprecipitated with b4. Note
that these experiments were performed on two distinct cell
lines that expressed different relative amounts of a6b1 and
a6b4 (Fig. 7 b, left and right). Taken together, these exper-
iments demonstrate that the anti-a6 mAb S3-41 reacts
with an epitope present only when a6 chains are linked to
b4 chains.
When Used in Soluble Form the a6b4-specific mAb
S3-41 Inhibits Proliferation of Thymocytes Stimulated 
via the CD3ÐTCR Complex
Anti-a6 antibodies were used in proliferation assays per-
formed on human thymocytes. To determine which lami-
nin 5 receptor is involved in the modulation of thymocyte
proliferation, we used GOH3 mAb which recognizes all a6
chains and S3-41 mAb which is a6b4 specific. As previously
described (58, 66), the anti-a6 mAb GOH3 immobilized
on culture wells delivered a strong costimulus for thy-
mocyte proliferation in the presence of cross-linked CD3
mAb (Fig. 8 a). Under the same conditions, S3-41 deliv-
ered a weak proliferative costimulus to thymocytes when
compared with GOH3. Moreover, there was no additive
or synergistic effect when the two mAbs GOH3 and S3-41
were immobilized on plates with a CD3 mAb. When anti-
a6 mAbs were used in soluble form, we observed that only
S3-41 inhibited proliferation of thymocytes stimulated via
the CD3ÐTCR complex (Fig. 8 b). Inhibition was very effi-
cient with S3-41 (50%). We tested the same soluble mAbs
on thymocytes stimulated with a mitogenic pair of CD2
mAbs (GT2 1 D66) (Fig. 9 a), the CD28 mAb and immo-
bilized CD3 mAb (Fig. 9 b), or the CD28 mAb and rIL-2
(Fig. 9 c). Again, an inhibitory effect was seen only when
thymocytes were stimulated via the CD3ÐTCR pathway.
We also used the anti-a3 mAb P1B5, which recognizes
the a3b1 epitope involved in laminin 5 binding (7, 48).
When added in soluble form in amounts ranging from
0.1 to 10 mg/ml, P1B5 did not inhibit proliferation of
thymocytes stimulated via the CD3ÐTCR complex (not
shown).
As it has been described that the non-integrin receptor
p67 can associate with a6b4 (2), it was of interest to test the
effects of an anti-p67 mAb, namely MPLR2, on T cell pro-
liferation. We did not observe a significant inhibition of
soluble MPLR2 on thymocyte proliferation induced via
the CD3ÐTCR complex (not shown).
Inhibition by Soluble S3-41 mAb of Early Kinase 
Phosphorylations Activated via the CD3ÐTCR Complex
We tested the effects of S3-41 and P1B5 mAbs, used in sol-
Figure 5. Inhibition by soluble laminin 5
(lam5) of early kinases phosphorylation
events activated via the CD3ÐTCR complex.
Jurkat cells at 20 3 106/ml in RPMI 5% FCS
were incubated with Abs at 378C for 2.5 min,
solubilized, and lysates were immunoprecipi-
tated with (a) a pAb antiÐZap 70, (b) a pAb
anti-lck, (c) a pAb anti-fyn. After SDS-
PAGE separation and electrotransfer onto
Immobilon P membrane, proteins were incu-
bated with HRP conjugated anti-phosphoty-
rosine Ab (APY) followed by ECL. For den-
sitometric analysis of APY immunoblotting,
control values were reduced to 1 in order to
compare signals after activation. Values are
mentioned under each lane. For reprobing, the membranes were submerged in stripping buffer, blocked and immuno-detected with (a)
pAb antiÐZap 70, (b) pAb anti-lck, and (c) pAb anti-fyn was performed. Reactions were revealed by incubating membranes with GAR
HRP followed by ECL. Laminin 5 (lam5) was added in soluble form at 1 mg/ml for Zap 70 and fyn analysis and 5 mg/ml for lck analysis.Vivinus-Nebot et al. Laminin 5 Control Human Thymocyte Proliferation via a6b4 569
uble form, on early kinase phosphorylation events (Fig.
10). Jurkat cells expressing a6b4 in similar density as
CD3high thymocytes were activated with a CD3 mAb (33,
10 mg/ml) during 2.5 min at 378C, with or without soluble
mAbs. Immunoprecipitation of Zap 70, p56lck, or p59fyn
was carried out on activated cell lysates. Precipitated pro-
teins were transferred onto Immobilon, then membranes
were incubated with an anti-phosphotyrosine antibody
coupled to peroxidase. Results were revealed by ECL. We
observed that the addition of S3-41 (10 mg/ml) induced the
same pattern of inhibition as soluble laminin 5 with inhibi-
tion of Zap 70 and p59fyn tyrosine phosphorylation (Fig.
10, a and c, respectively) but no inhibition of overall p56lck
(Fig. 10 b). In contrast, addition of soluble P1B5 (10 mg/ml)
did not induce this particular pattern of reactivity, sup-
porting the hypothesis that a6b4 is the laminin 5 receptor
involved.
Discussion
Using mAbs specific for the three chains of laminin 5
Figure 6. (a) The anti-a6 integrin chain mAb S3-41 has a peculiar
pattern of reactivity with human thymocytes, resembling the re-
activity of the anti-b4 chain mAb. Two color immunofluores-
cence was performed on human thymocytes with the CD3 mAb
X3 directly conjugated with FITC and with the indicated
amounts of anti-integrin mAb that was indirectly labeled with
goat antiÐmouse PE conjugated F(ab)92 fragments. The percent-
age of positive cells for the integrin chain analyzed is noted in the
upper corner of the corresponding area. a6 expression was ana-
lyzed with the mAbs GOH3 and S3-41; b1 expression was ana-
lyzed with the mAb K20 and b4 expression was analyzed with the
mAb 3E1F6. (b) Reactivities of the anti-a6 mAb S3-41 and
GOH3 and of the anti-b4 mAb 3E1F6 with thymocyte subpopu-
lations according to their surface density in CD3. The percentage
in the upper right corner indicates the number of positively
stained cells. All antibodies were used at saturating doses, i.e., 10
mg/ml for S3-41, 3E1F6, K20 and 5 mg/ml for GOH3 and X3.
Figure 7. (a) Sequential immunoprecipitations of a6, b1, or b4
chains from HT29 colon carcinoma cell line after anti-b1 or anti-
b4 immunoprecipitations (IP). (Left) IP with anti-b1 mAb K20,
anti-a6 mAb S3-41, anti-a6 mAb GOH3, and anti-b4 mAb
3E1F6 were performed on total cell lysates. (Middle) To deplete
lysates of b1 integrins, a first IP with the anti-b1 mAb K20 was
performed on cell lysates and a second IP was then carried out on
the supernatants using the same mAb. Finally, a third immuno-
precipitation was carried out on the supernatants with the indi-
cated mAbs. (Right) To deplete lysates of a6b4, a first IP with the
anti-b4 mAb 3E1F6 was performed on cell lysates and a second
IP was then performed on the supernatants using the same mAb.
Finally, a third immunoprecipitation was performed on the su-
pernatants with the indicated mAbs. Controls showed that the
material recovered was efficiently depleted in b1 (middle panel,
lane 1) or b4 chains (right panel, lane 4), respectively. Immuno-
precipitated proteins were separated on SDS-PAGE 7.5%, under
reducing conditions. Results were revealed by autoradiography.
(b) Immunoblots with the anti-a6 mAb S3-41 were performed on
immunoprecipitates obtained with mAbs K20 (anti-b1), 3E1F6
(anti-b4) and GOH3 (anti-a6) on lysates from (left) HT29 cells
that express a6b4 at higher density than a6b1 or (right) K562 cells
that express a6b1 at higher density than a6b4. Immunoprecipi-
tated proteins were separated on SDS-PAGE 7.5%, under reduc-
ing conditions before blotting. Immunolabeling was revealed by
chemiluminescence (ECL) after reaction with goat antiÐmouse
immunoglobulins conjugated with HRP.The Journal of Cell Biology, Volume 144, 1999 570
(anti-a3 mAb BM165, anti-b3 mAb 6F12, anti-g2 mAb
GB3), we have investigated the presence and cellular dis-
tribution of laminin 5 on frozen human thymus sections. It
has been mentioned in earlier publications that laminin 5
is expressed in the human thymus (25, 42, 72). Our data fo-
cus on laminin 5 expression in thymic parenchyma and
link up with functional effects of this molecule on thy-
mocyte proliferation. Since we have found an identical re-
activity of the three mAbs, it can be concluded that a com-
plete form of laminin 5 is displayed by the thymus. Indeed,
it is known that b3g2 modules can be expressed without
any detectable a3 chains, such as in choroid plexus (1). We
have observed that laminin 5 has quite a particular expres-
sion in the thymus; it can be detected in the medulla where
a subpopulation of epithelial cells displays laminin 5 as re-
vealed by double staining with keratin. For double staining
we used the anti-keratin Ab CK19 that recognizes all epi-
thelial cells (71). Whether the laminin 5 epithelial cells
form a specialized set of cells or whether any epithelial
cells in these areas could become laminin 5 positive under
certain circumstances of stimulus remains to be estab-
lished. However, this feature is additional to the similari-
ties previously described between thymic epithelial cells
and epidermal keratinocytes (45). Thymic vessels are also
strongly stained with anti-laminin 5 antibody, particularly
at the level of basal laminae, including capillary structures.
It is more difficult to ascertain that endothelial cells are
Figure 8. Effects of anti-a6 chain mAb S3-41, added, either in
cross-linked or soluble form, on thymocyte proliferation. (a) S3-41
or GOH3 and CD3 were cross-linked on plastic from culture
wells as indicated in Fig. 2 before adding the thymocyte suspen-
sion. (b) CD3 was first cross-linked on plastic from culture wells.
FCS in culture medium was incubated for 2 h at 378C to saturate
the plastic, before adding IL-2, S3-41, or GOH3 in solution and
the thymocyte suspension. The indicated mAbs were added at
10 mg/ml.
Figure 9. Effects of anti-a6 chain mAb S3-41, added in soluble
form, on thymocyte proliferation induced by several pathways.
(a) Cells were stimulated with a mitogenic pair of CD2 mAbs
(GT2 and D66, 10 mg/ml) plus IL-2. The indicated mAbs were
added in soluble form at saturating dose (10 mg/ml). (b) Cells
were stimulated with plate-bound CD3 and soluble CD28 mAb
(9.3, 1/500). (c) Cells were stimulated with soluble CD28 mAb 9.3
and rIL-2. Various amounts of S3-41 were added in soluble form
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also stained; this staining is irregular and is restricted to
larger vessels. Interestingly, preliminary results indicate
that, in humans, small vessels and capillary structures from
other organs appear devoid of laminin 5. In the thymus,
vessels are abundant in the medulla, particularly at the
corticomedullary junction and it is likely that emigration
of thymocytes having reached maturation occurs in this
area. Indeed, laminin 5 has been involved in various cell
migration phenomena in wound repair (63) or tumor inva-
sion (26, 27, 41) involving cleavage by metalloproteases
(17). Therefore, the present data raise the possibility of a
role for laminin 5 in T cell migration outside the thymus.
The intensity of BM165 staining at the corticomedullary
junction suggests that laminin 6 and/or 7 may be also
present in these areas. Laminin 5 is also present in subcor-
tical flat epithelial basement membrane that is also known
to include hemidesmosome components like collagen type
VII and a6b4 integrins (50, 72). It is thus likely that laminin
5 in this region has a different function to the laminin 5
present in the thymus parenchyma, which would be similar
to the structural role it exerts in the basement membrane
of skin and other epithelia.
Whereas laminin 5 has been identified as a ligand for
both a3b1 and a6b4 integrins in vitro, (7, 44, 48, 60), we
have observed that a3b1 and a6b4 have a quite distinct dis-
tribution on human thymocytes in vivo. Whereas it was
found that a3b1 is evenly distributed on all thymocyte sub-
sets (43), we have shown here that a6b4 density on the sur-
face of thymocytes parallels their maturation. We have
used the mAb S3-41 (24) because we found that it reacts
only with the a6 chains linked to the b4 chain, and not
with the a6 chains linked to the b1 chain. Although this
mAb was classified as CD49f by the International Work-
shops on Leucocyte Antigens on the basis of its capacity to
recognize human a6 transfected in RBL rat cells (22), a
particular reactivity was noticed on skin sections, where a6
is associated with the b4 chain, but not on kidney sections,
where a6 is associated with the b1 chain (28, 77). The se-
quential immunoprecipitations and immunoprecipitations
followed by Western blots that were performed in the
present study confirmed that S3-41 mAb reacts exclusively
with the a6 chain bound to b4. We have noticed that, on
total lysates, S3-41 immunoprecipitated much less material
than anti-a6 mAb GOH3. This could be explained either
by a difference of affinity between the two mAbs and/or
by the staining of only a subpopulation of a6 chains with
S3-41. Indeed, S3-41 mAb did not precipitate any material
when lysates were depleted of b4 integrins but it was fully
reactive when lysates were depleted of b1 integrins, and
only a6 chains coimmunoprecipitated with b4 carried the
S3-41 epitope. Moreover, as S3-41 reacted with a6 chains
separated from b4 chains, this suggests that it recognizes
an intrinsic isomorphism of the a6 chains and not a confor-
mational epitope. Thus, strikingly, a6b4 upregulation on
mature thymocytes coincides with laminin 5 expression in
the medullary area, the thymic region where mature thy-
mocytes are located. In mice, it has been described that, on
the contrary, downregulation of b4 is simultaneous with
the upregulation of CD4, CD8, and CD3 (73), but differ-
ences in integrin expression with T cell maturation be-
tween human and mouse have already been observed for
a4b1 (55).
Since it was described that bulk preparations of laminin
coated on plastic are strongly mitogenic for T cells (58), it
was of interest to investigate the effect of laminin 5 on hu-
man T cell proliferation. We show here that laminin 5 pre-
sented in a cross-linked form has only a slight coactivation
effect on thymocytes. However, when presented in soluble
form, a clear inhibition of proliferation triggered via the
CD3ÐTCR complex was observed. It should be noted that
this effect was reproduced by the anti-a6 mAb S3-41; how-
ever, it was not reproduced by the typical anti-a3 integrin
mAb P1B5 in agreement with the view that the inhibitory
influence of soluble laminin 5 on T cell proliferation is me-
diated via a6b4. In addition, we did not observe an inhibi-
tion on TCR triggered proliferation with soluble mAb
MPLR2, an antibody reacting with the high affinity non-
integrin p67 laminin receptor, reported to be associated
with  a6b4 (2). Soluble laminin can be detected in the serum
of normal individuals, and its level was found to be
strongly increased in inflammatory conditions and certain
autoimmune disorders (57, 75). Laminin is also present in
the extracellular spaces of secreting cells, and it was found
that a significant proportion (z15%) of Engelbreth Holm
Figure 10. Inhibition by soluble anti-a6 mAb S3-41 of
early kinases phosphorylation events activated via the
CD3ÐTCR complex. Jurkat cells at 20 3 106/ml in
RPMI 5% FCS were incubated with Abs at 378C for 2.5
min, solubilized, and lysates were immunoprecipitated
with (a) a pAb antiÐZap 70, (b) a pAb anti-lck, (c) a
pAb anti-fyn. After SDS-PAGE separation and elec-
trotransfer onto Immobilon P membrane, proteins
were incubated with HRP conjugated anti-phosphoty-
rosine Ab (APY) followed by ECL. For reprobing, the
membranes were submerged in stripping buffer,
blocked, and immunodetected with (a) pAb antiÐZap
70, (b) pAb anti-lck, (c) pAb anti-fyn was performed.
Reactions were revealed by incubating membranes
with GAR HRP followed by ECL. For densitometric
analysis of APY immunoblotting, control values were reduced to 1 in order to compare signals after activation. Values are mentioned
under each lane. Anti-integrin antibodies were added in soluble form at 10 mg/ml.The Journal of Cell Biology, Volume 144, 1999 572
Swarm matrix proteins is present as a soluble form re-
leased into the supernatant (47). It is likely that an equilib-
rium takes place between the soluble laminins, either re-
leased by secreting cells or liberated from the ECM on the
one hand, and the laminin deposited as an insoluble frac-
tion in the ECM or on cell surface receptors on the other
hand (47). The data presented here disclose a cross-talk
event occurring between the laminin 5 receptor a6b4 and
the T cell receptor. Of note, inhibition induced by laminin
5 is restricted to signaling via the CD3ÐTCR complex, and
we observed no inhibition when T cells were stimulated
via other pathways such as the CD2 or the CD28 path-
ways. Inhibition by laminin 5 therefore shares similarities
with the inhibition generated by b1 integrin ligands we
have described, either VCAM 1 or mAbs (19, 65, 34). It
has been previously shown by other groups that integrins
can negatively regulate T cell activation (21, 36, 64). Our
data show that a6b4 can also modulate T cell activation.
Consistent with this view, it has been previously suggested
that this integrin could, depending on the cell type, either
increase or block normal cell proliferation (16). Besides,
as an activation pathway was previously described when
a6b4 was ligated with coated antibodies or laminin 5 (32),
our data obtained with soluble ligand and mAb suggest
also that exposing cells to immobilized or soluble ligands
can trigger different signaling pathways. Such influences,
depending on the form of the ligand, fits well with the
known feature of integrins signaling, whose pattern is criti-
cally dependent on sole ligand occupancy, sole integrin ag-
gregation or both ligand occupancy and aggregation (40).
Moreover, we have observed here that laminin 5 inhibits
the phosphorylation of Zap 70 and p59fyn but has no effect
on overall phosphorylation and activation of p56lck, a pat-
tern of kinase inhibition that was also observed in our lab-
oratory by binding b1 integrins with soluble ligand (34).
Thus a6b4, under the influence of laminin 5 appears to use,
at least in part, the same intracellular signaling pathway as
b1 integrins under the influence of VCAM 1. Whether
these signaling pathways are common or whether they di-
verge deserves further investigation.
There is increasing evidence that integrins and their
ligands, including ECM components, play a critical role in
T cell maturation (5, 10, 12, 20, 31, 43, 54Ð56, 69, 73, 74).
The pattern of expression of the various integrins present
in the thymus and the pattern of expression of their ligand
are both subtle events that account for their influence at
given stages of T cell differentiation/maturation (12, 54).
Since, it is clear that thymocyte differentiation involves cy-
cles of proliferation and arrest (18), the coordination of
adhesion and proliferation events mediated by laminin
sub-types is likely to be significant for T cell maturation.
The results reported here suggest that laminin 5 might be
an important signaling molecule in the control of expan-
sion of mature thymocytes and possibly their migration
outside the thymus, given its presence in vascular struc-
tures.
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